Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/1996
09/04/1996EP0560932B1 Methods and compositions for the suppression of neu mediated transformation
09/04/1996EP0535104B1 Heterocyclic compounds and their preparation and use
09/04/1996EP0504184B1 Active agent against retrovirus group viruses, compositions containing same and their use
09/04/1996EP0355131B1 Acyl deoxyribonucleoside derivatives and uses thereof
09/04/1996CN1130401A Regulated apoptosis
09/04/1996CN1130382A Process for preparation of 9-(2-hydroxy)-ethoxymethyl-guanine
09/04/1996CN1130381A Use of coumarins and carbostyrils as PLAZ inhibitors, new coumarins and carbostyrils, process for prep, the same and medicaments
09/04/1996CN1130379A Substituted oxazine and thiazine oxazolidinone antimicrobials
09/04/1996CN1130354A Compositions containing amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of decongestant an expectorant, an antihistamine and an antitussive
09/04/1996CN1130352A Controlled-releasing opioid formulations for treating pain
09/04/1996CN1130350A Dermatologic preparation
09/04/1996CN1130188A Salt of phosphonocarboxyl sulfonate zoomaricoene synthetic inhibitor and method
09/04/1996CN1130186A Ethers substituted by dicycle oxazole and thiazole
09/04/1996CN1130184A New Tricyclic amide compounds, processes for their preparation and the pharmaceutical compositions which contain them
09/04/1996CN1130180A Amino (thio) ether derivative
09/04/1996CN1130178A Alkyl-5-melhy/sulfonylbenzoy/guanidine derivatives
09/04/1996CN1130065A Compound ketoconazole external-use preparation
09/04/1996CN1130064A Solid medicinal composition containing ecipient capable of combining water
09/04/1996CN1130063A Estogen effect promoting medicine
09/04/1996CN1130062A Syringene oxide used as antifungal
09/04/1996CN1130060A Ketopheny/propionate plastid
09/04/1996CN1130059A Use of an agonisl substances of a receptors associated with a chlorine channel in the treatment of wrinkles
09/04/1996CN1032675C Concentrated water solution containing spiramycin depressor for intravenous injection after dilution
09/04/1996CA2170844A1 Pharmaceutical compositions containing dinoreburnamenine derivatives
09/03/1996US5552558 Retroviral protease inhibiting compounds
09/03/1996US5552553 N-(3-hydroxy-4-piperidinyl) (dihydrobenzofuran, dihydro-2H-benzopyran or dehydrobenzodioxin) carboxamide derivatives
09/03/1996US5552552 Enzyme inhibitors for lipidperoxidase for treatment of stroke
09/03/1996US5552545 5-deaza-10-oxo-and 5-deaza-10-thio-5,6,7,8-tetrahydrofolic acids
09/03/1996US5552544 Antitumor agents
09/03/1996US5552541 Haptenic probes for detecting capture polynucleotides
09/03/1996US5552446 Emulsion containing stabilized ascorbic acid, cosmetic treatment process using it and uses thereof
09/03/1996US5552445 Composition for external skin care
09/03/1996US5552444 Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes, 3-aminochromanes, and 3-aminothiochromanes
09/03/1996US5552442 Therapeutic applications of clenbuterol
09/03/1996US5552440 Use of L-canavanine as a chemotherapeutic agent for the treatment of pancreatic cancer
09/03/1996US5552439 Aminophenol derivatives
09/03/1996US5552438 Compounds useful for treating allergic and inflammatory diseases
09/03/1996US5552437 Bisarylcarbinol derivatives as inhibitors of leukotriene biosynthesis
09/03/1996US5552436 Process for treating hemangioma
09/03/1996US5552435 Benzopyran and related LTB antagonists
09/03/1996US5552434 7-(5-substituted cyclopentyl) and (5-substituted cyclopentenyl) heptyl alcohols, heptylamines and heptanoic acid amides, and method of lowering intraocular pressure in the eye of a mammal by administration of these compounds
09/03/1996US5552433 Method for lowering serum cholesterol
09/03/1996US5552430 Antiretroviral compounds
09/03/1996US5552429 Administering fluoxetine and pindolol to increase availability of serotonin, dopamine and norepinephrine
09/03/1996US5552428 Antiarrhythmia agents for cardiovascular disorders using melatonin derivatives
09/03/1996US5552427 Glutaminase inhibitory compounds, compositions, and methods of use
09/03/1996US5552426 Methods for treating a physiological disorder associated with β-amyloid peptide
09/03/1996US5552424 Isoxazolines as antiinflammatory agents
09/03/1996US5552422 Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents
09/03/1996US5552421 Leukotriene biosynthesis inhibitors
09/03/1996US5552419 Arylsulfonamido-substituted hydroxamic acids
09/03/1996US5552418 Trisubstituted Naphthylalkylamides
09/03/1996US5552417 Preventing premature sexual maturity, benzothiophene derivatives
09/03/1996US5552416 Methods of inhibiting dysfunctional uterine bleeding
09/03/1996US5552415 Cognition activators
09/03/1996US5552414 Antipsychotic agents and analgesics
09/03/1996US5552413 Methods for inhibiting hyperproliferation of kerntinocytes
09/03/1996US5552412 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis
09/03/1996US5552406 Administering buprenorphine to a patient
09/03/1996US5552405 Substituted pyrrolidine derivatives as HIV protease inhibitors
09/03/1996US5552404 Compounds for neurotransmitters for animals
09/03/1996US5552403 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
09/03/1996US5552401 2-benzyl-3-arylbenzothiophenes
09/03/1996US5552400 Inhibitors of protease activity
09/03/1996US5552398 Treatment of irritable bowel diarrhea
09/03/1996US5552396 Bis-indolemaleimide macrocyclic derivatives,
09/03/1996US5552395 Bone disorders
09/03/1996US5552394 Ethinyl estradiol and norethindrone acetate
09/03/1996US5552392 Method of treating hypoparathyroidism with (20S) vitamin D compounds
09/03/1996US5552391 Chemically-defined non-polymeric valency platform molecules and conjugates thereof
09/03/1996US5552389 Suppressory compositions against hepatic metastases of tumors
09/03/1996US5552384 Antiherpes compositions and method of use
09/03/1996US5552323 Method of blending an anticoagulant
09/03/1996US5552311 Purine nucleoside phosphorylase gene therapy for human malignancy
09/03/1996US5552271 RXR homodimer formation
09/03/1996US5552161 Low viscosity, highly concentrated surfactant suspension
09/03/1996US5552158 Skin care composition
09/03/1996US5552157 Quaternary ammonium lipids
09/03/1996US5552156 Liposomal and micellular stabilization of camptothecin drugs
09/03/1996US5552154 Method for treating cancer with water-insoluble s-camptothecin of the closed lactone ring form and derivatives thereof
09/03/1996US5552153 Pharmaceutical composition for transdermal delivery
09/03/1996US5552152 Controlled release tablet
09/03/1996US5552150 Compostions containing di-linoleoyl-mono-gamma-linolenyl-glycerol
09/03/1996US5552148 Cosmetic composition with petrolatum and phosphatides
09/03/1996CA2169804A1 Antimigraine 1,2,5-thiadiazole derivatives of indolylalkyl-pyridinyl and pyrimidinylpiperazines
09/03/1996CA2076658C Hyperglycemic compositions
09/03/1996CA2059632C Reveromycin a, method for preparing same, and antitumor agent and antifungal agent comprising the same
09/03/1996CA2033113C Estrogen-containing gel preparation
09/03/1996CA2008972C Nifedipine-containing pharmaceutical compositions and process for the preparation thereof
09/03/1996CA2007785C 1-[3-(2-hydroxy-3-alkylaminopropoxy)-2-thienyl] -3-phenyl-1-propanones and a process for the preparation thereof
09/03/1996CA1338572C Amino acid esters, process for the preparation thereof and use thereof
09/03/1996CA1338571C 3-(substituted)-1-carba (dethia)-3-cephems and cephalosporins and a process for production therefor
09/03/1996CA1338569C Controlled release therapeutic system for liquid pharmaceutical formulations
08/1996
08/29/1996WO1996026288A1 A method for the isolation and purification of lipid cell-wall components
08/29/1996WO1996026285A2 Methods and compositions for administering gene therapy vectors
08/29/1996WO1996026275A1 Dna molecule encoding for cellular uptake of mycobacterium tuberculosis and uses thereof
08/29/1996WO1996026209A1 Stable hydrates of a cephalosporin chloride salt
08/29/1996WO1996026205A1 Inhibitors of microsomal triglyceride transfer protein and method
08/29/1996WO1996026201A1 Benzopyran-containing compounds and method for their use
08/29/1996WO1996026196A2 Benzylpiperidines and piperazines as muscarinic antagonists
1 ... 6884 6885 6886 6887 6888 6889 6890 6891 6892 6893 6894 6895 6896 6897 6898 6899 6900 6901 6902 6903 6904 ... 7860